Literature DB >> 1996750

Response to suxamethonium in a myasthenic patient during remission.

M Abel1, J B Eisenkraft, N Patel.   

Abstract

A cumulative dose followed by an infusion was used to determine the dose response to suxamethonium in a patient with diagnosed myasthenia gravis who was in true remission (asymptomatic while receiving no therapy). The ED50 and ED90 values for suxamethonium were 0.08 mg/kg and 0.20 mg/kg, and an infusion rate of 3.2 mg/kg/hour was required to maintain a 90-95% depression of the single twitch response as monitored by integrated electromyography. These values are within the range for normal patients, and we conclude that myasthenic patients during a true remission may not demonstrate resistance to suxamethonium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996750     DOI: 10.1111/j.1365-2044.1991.tb09310.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  Sevoflurane-induced sensitivity of neuromuscular function in a patient with myasthenia gravis in true remission.

Authors:  J Takeda; Y Ohnishi; T Koitabashi; K Fukushima
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

Review 2.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

3.  A Complicated Case of Postpartum Myasthenic Crisis.

Authors:  Ryan Quigley; Zachary A Koenig; Samuel Schick; Erin Miller
Journal:  Cureus       Date:  2021-12-07

4.  Successful administration of electroconvulsive therapy in a patient with treatment-resistant schizophrenia and coexisting myasthenia gravis.

Authors:  Vanteemar S Sreeraj; Sudhir Venkataramaiah; Aditya Sunka; Sriganesh Kamath; Naren P Rao
Journal:  Indian J Psychiatry       Date:  2019 Nov-Dec       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.